Athenex investor relations material

Listen to the latest call from Athenex

Athenix Inc is a biopharmaceutical company engaged in the development and commercialization of drugs for the treatment of cancer. The company's Orascovery product candidates include Oral paclitaxel and encequidar, an oral dosage form, which is in Phase III trial for metastatic breast cancer, as well as various clinical studies in cutaneous angiosarcoma, advanced gastric cancer, and advanced solid malignancies. It also offers Src Kinase product candidates comprising Tirbanibulin ointments for actinic keratosis, skin cancers, and psoriasis.

  • Ticker

  • Country


Dig deeper into the Athenex fundamentals on Quartr.